News and Features
04-03-2018
New Sidekicks™ Program Designed to Build Positive Connections for People with Parkinson’s and Youth through Intergenerational Storysharing
03-16-2018
Lundbeck to acquire Prexton Therapeutics adding foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson’s disease